These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20394377)

  • 21. Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants.
    Benned-Jensen T; Rosenkilde MM
    Br J Pharmacol; 2010 Mar; 159(5):1092-105. PubMed ID: 20148890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine.
    Fumagalli M; Lecca D; Coppolino GT; Parravicini C; Abbracchio MP
    Adv Exp Med Biol; 2017; 1051():169-192. PubMed ID: 28828731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of select oxysterols as ligands for GPR17.
    Harrington AW; Liu C; Phillips N; Nepomuceno D; Kuei C; Chang J; Chen W; Sutton SW; O'Malley D; Pham L; Yao X; Sun S; Bonaventure P
    Br J Pharmacol; 2023 Feb; 180(4):401-421. PubMed ID: 36214386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural analysis of human G-protein-coupled receptor 17 ligand binding sites.
    Konda Mani S; Thiyagarajan R; Yli-Harja O; Kandhavelu M; Murugesan A
    J Cell Biochem; 2023 Apr; 124(4):533-544. PubMed ID: 36791278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of new chromatographic tools based on A2A adenosine receptor subtype for ligand characterization and screening by FAC-MS.
    Temporini C; Massolini G; Marucci G; Lambertucci C; Buccioni M; Volpini R; Calleri E
    Anal Bioanal Chem; 2013 Jan; 405(2-3):837-45. PubMed ID: 22960794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G-protein-coupled receptor chromatographic stationary phases. 2. Ligand-induced conformational mobility in an immobilized beta2-adrenergic receptor.
    Beigi F; Chakir K; Xiao RP; Wainer IW
    Anal Chem; 2004 Dec; 76(24):7187-93. PubMed ID: 15595859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel GPR17-agonists by structural bioinformatics and signaling activation.
    Saravanan KM; Palanivel S; Yli-Harja O; Kandhavelu M
    Int J Biol Macromol; 2018 Jan; 106():901-907. PubMed ID: 28827203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontal affinity chromatography with MS detection (FAC-MS) in drug discovery.
    Slon-Usakiewicz JJ; Ng W; Dai JR; Pasternak A; Redden PR
    Drug Discov Today; 2005 Mar; 10(6):409-16. PubMed ID: 15808820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Heterodimerization between the G Protein-Coupled Receptor GPR17 and the Chemokine Receptors 2 and 4: New Evidence.
    Daniele S; Saporiti S; Capaldi S; Pietrobono D; Russo L; Guerrini U; Laurenzi T; Ataie Kachoie E; Palazzolo L; Russo V; Abbracchio MP; Eberini I; Trincavelli ML
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enigmatic GPCR finds a stimulating drug.
    Harden TK
    Sci Signal; 2013 Oct; 6(298):pe34. PubMed ID: 24150253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frontal affinity chromatography with MS detection of the ligand binding domain of PPARγ receptor: ligand affinity screening and stereoselective ligand-macromolecule interaction.
    Calleri E; Fracchiolla G; Montanari R; Pochetti G; Lavecchia A; Loiodice F; Laghezza A; Piemontese L; Massolini G; Temporini C
    J Chromatogr A; 2012 Apr; 1232():84-92. PubMed ID: 22056242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Orphan G Protein-coupled Receptor GPR17 Negatively Regulates Oligodendrocyte Differentiation via Gαi/o and Its Downstream Effector Molecules.
    Simon K; Hennen S; Merten N; Blättermann S; Gillard M; Kostenis E; Gomeza J
    J Biol Chem; 2016 Jan; 291(2):705-18. PubMed ID: 26620557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand binding to a G protein-coupled receptor captured in a mass spectrometer.
    Yen HY; Hopper JTS; Liko I; Allison TM; Zhu Y; Wang D; Stegmann M; Mohammed S; Wu B; Robinson CV
    Sci Adv; 2017 Jun; 3(6):e1701016. PubMed ID: 28630934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerating the Throughput of Affinity Mass Spectrometry-Based Ligand Screening toward a G Protein-Coupled Receptor.
    Lu Y; Qin S; Zhang B; Dai A; Cai X; Ma M; Gao ZG; Yang D; Stevens RC; Jacobson KA; Wang MW; Shui W
    Anal Chem; 2019 Jul; 91(13):8162-8169. PubMed ID: 31094506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated multiple ligand screening by frontal affinity chromatography-mass spectrometry (FAC-MS).
    Ng W; Dai JR; Slon-Usakiewicz JJ; Redden PR; Pasternak A; Reid N
    J Biomol Screen; 2007 Mar; 12(2):167-74. PubMed ID: 17218664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17.
    Buccioni M; Marucci G; Dal Ben D; Giacobbe D; Lambertucci C; Soverchia L; Thomas A; Volpini R; Cristalli G
    Purinergic Signal; 2011 Dec; 7(4):463-8. PubMed ID: 21773766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of G protein-coupled receptor 17 in central nervous system injury].
    Zhang Z; Wei E; Lu Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May; 42(3):355-9. PubMed ID: 23801627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontal affinity chromatography in characterizing immobilized receptors.
    Calleri E; Temporini C; Massolini G
    J Pharm Biomed Anal; 2011 Apr; 54(5):911-25. PubMed ID: 21190807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing HAMI3379 to Block GPR17 and Promote Rodent and Human Oligodendrocyte Differentiation.
    Merten N; Fischer J; Simon K; Zhang L; Schröder R; Peters L; Letombe AG; Hennen S; Schrage R; Bödefeld T; Vermeiren C; Gillard M; Mohr K; Lu QR; Brüstle O; Gomeza J; Kostenis E
    Cell Chem Biol; 2018 Jun; 25(6):775-786.e5. PubMed ID: 29706593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis.
    Parravicini C; Lecca D; Marangon D; Coppolino GT; Daniele S; Bonfanti E; Fumagalli M; Raveglia L; Martini C; Gianazza E; Trincavelli ML; Abbracchio MP; Eberini I
    PLoS One; 2020; 15(4):e0231483. PubMed ID: 32320409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.